Naloxone, the life-saving drug used to treat opioid overdose, is shown to reduce brain inflammation in the aftermath of stroke in male rats. The preclinical research, by scientists at the NIDA Intramural Research Program, partnering with investigators from Colorado, Taiwan and Finland, lays the groundwork for developing the first drug to promote recovery from ischemic stroke, a leading cause of adult disability.
This is Archived Content. This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA). View current news releases on nida.nih.gov.